The urgency of providing comprehensive and integrated treatment for substance abusers with HIV
about
Examining the Acceptability of mHealth Technology in HIV Prevention Among High-Risk Drug Users in Treatment.Developing an Integrated, Brief Biobehavioral HIV Prevention Intervention for High-Risk Drug Users in Treatment: The Process and Outcome of Formative Research.Attitudes and Training Needs of New England HIV Care and Addiction Treatment Providers: Opportunities for Better Integration of HIV and Alcohol Treatment Services.The Relationship Between Drug Use, Drug-related Arrests, and Chronic Pain Among Adults on Probation.Utilization and outcomes of detoxification and maintenance treatment for opioid dependence in publicly-funded facilities in California, USA: 1991-2012.A qualitative study of barriers to and facilitators of optimal engagement in care among PLWH and substance use/misuse.A call for evidence-based medical treatment of opioid dependence in the United States and Canada.Spillover effects of HIV testing policies: changes in HIV testing guidelines and HCV testing practices in drug treatment programs in the United States.Patient characteristics and availability of onsite non-rapid and rapid HIV testing in US substance use disorder treatment programsImpact of Illicit Drug Use on Health-Related Quality of Life in Opioid-Dependent Patients Undergoing HIV Treatment.Directly administered antiretroviral therapy: pilot study of a structural intervention in methadone maintenance.Sleep disturbances in persons living with HIVA non-inferiority trial of an evidence-based secondary HIV prevention behavioral intervention compared to an adapted, abbreviated version: Rationale and intervention description.A pilot study of sleep quality and rest-activity patterns in persons living with HIV.On-site bundled rapid HIV/HCV testing in substance use disorder treatment programs: study protocol for a hybrid design randomized controlled trial.Short term health-related quality of life improvement during opioid agonist treatmentIntegrating substance abuse treatment into HIV care: missed opportunities in the AIDS Drug Assistance Program.HIV infection among people who inject drugs: the challenge of racial/ethnic disparities.Substance abuse treatment implementation research.HIV testing in the nation's opioid treatment programs, 2005-2011: the role of state regulationsAn international systematic review and meta-analysis of multisession psychosocial interventions compared with educational or minimal interventions on the HIV sex risk behaviors of people who use drugs.A mixed methods study of HIV-related services in buprenorphine treatment.Modeling a Theory-Based Approach to Examine the Influence of Neurocognitive Impairment on HIV Risk Reduction Behaviors Among Drug Users in TreatmentCorrelates of willingness to initiate pre-exposure prophylaxis and anticipation of practicing safer drug- and sex-related behaviors among high-risk drug users on methadone treatment.Estimating State Transitions for Opioid Use Disorders.The costs of crime during and after publicly funded treatment for opioid use disorders: a population-level study for the state of California.The HIV Care Cascade Among Individuals Under Community Supervision in Baltimore, Maryland.Willingness to Use Pre-Exposure Prophylaxis (PrEP): An Empirical Test of the Information-Motivation-Behavioral Skills (IMB) Model among High-Risk Drug Users in Treatment.Treatment Engagement Moderates the Effect of Neurocognitive Impairment on Antiretroviral Therapy Adherence in HIV-Infected Drug Users in Treatment.Examining the efficacy of a computer facilitated HIV prevention tool in drug court.HIV prevention, treatment, and care for people who inject drugs.The effects of opioid-agonist treatments on HIV risk and social stability: A mixed methods study of women with opioid use disorder in Ukraine.Antiretroviral therapy (ART) adherence and correlates to nonadherence among people on ART in Estonia.Measuring Acceptability and Preferences for Implementation of Pre-Exposure Prophylaxis (PrEP) Using Conjoint Analysis: An Application to Primary HIV Prevention Among High Risk Drug Users.Integrated Bio-behavioral Approach to Improve Adherence to Pre-exposure Prophylaxis and Reduce HIV Risk in People Who Use Drugs: A Pilot Feasibility Study.Training in Evidence-Based Practices Increases Likelihood to Integrate Different HIV Prevention Services with Substance-Using Clients.Is substance use associated with HIV cascade outcomes in Latin America?
P2860
Q33452059-66E202DE-8D05-472F-8F4B-4FD84DD18158Q33658647-0324FC00-BA05-467A-AA58-E4450EAB3BB2Q35136597-338485BA-50BE-42CD-BEE9-E4681A75611CQ35553915-520FFA3F-4E7C-48DA-9B43-AF370463B940Q35795201-2CA66463-0EAC-4536-B69C-9E9C5A1896E3Q35996628-B24C5242-A7CA-4C15-B3C3-B4BD4D70408CQ36062082-4DE76BE0-E98D-49F7-B10E-6209C073E9EEQ36090286-41AEEA83-CFC1-467E-90D1-2640686982DBQ36129595-8D18FD70-71B4-4839-A531-515A7D7851EFQ36167178-BA0F6197-7086-43AD-8678-F6727748F5F2Q36356751-FF2D43B0-9CC2-42E8-9174-1C2E8457335AQ36528391-BF50DCA2-45FA-4A9F-8987-D43D480C4005Q36552540-5B41E330-9AA8-42F9-B0DF-664B64D09D4DQ36640310-77DC3B99-A7A9-4F59-ADBF-3FE7C3632873Q36646287-98D916CD-D53A-4309-A4AF-F0E97B6230EDQ36652120-64D43887-F602-455F-857C-32F195D3FF15Q36828348-E702A0BB-BBFE-4D88-8ACB-CFD23CC76699Q37009231-BAFAAB3D-3BE3-4812-9EDE-7EAB4CF98F8DQ37032786-070085C6-737B-4F56-8716-E18579F090E7Q37339543-033CBA51-FAAA-4463-B6A7-E259FCAF6B7EQ38079532-AA061190-F280-4490-A531-EA425EE5E9F8Q38621655-5E62AFF0-8B31-496A-B3EC-E121C1F1C270Q38884773-B325F888-4ACF-4E32-94E1-A9BADB8006B7Q38954055-B039CD5A-511F-49A6-886D-B3F8414B1EC9Q39062397-A8937670-E8AC-4967-931B-49B5DCF8F0DFQ39095973-96E83531-9AB0-4E3F-8ADC-613A59B90B07Q40119830-FBD0B22B-6385-4EFE-BB1F-00FEEFD15868Q40404705-16AB4032-135B-4189-8BD7-8519B2FE6E5EQ40492630-E2059017-9FF0-4615-9211-4426AFB5F67BQ40757867-1D1384CD-1619-4410-98AC-7917A84EF9F4Q43108769-C18B66C2-16ED-4584-97DA-57946350C7A4Q44350723-0F506FF0-40E1-4BCB-BB66-A7B3C07AADC6Q44393596-359D7B60-BF9D-42A7-A4EE-986AE79FDE02Q48147782-4905AB01-D02B-44F7-A454-DA2F3F624C7CQ51734189-91CDB397-75BB-49A6-8C72-BA76D04A6732Q51746564-2BE9871D-690C-49ED-9977-FE7659EB6D29Q54983898-9EF3859D-26DB-416D-9BD0-6551505F0B3C
P2860
The urgency of providing comprehensive and integrated treatment for substance abusers with HIV
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The urgency of providing compr ...... for substance abusers with HIV
@ast
The urgency of providing compr ...... for substance abusers with HIV
@en
type
label
The urgency of providing compr ...... for substance abusers with HIV
@ast
The urgency of providing compr ...... for substance abusers with HIV
@en
prefLabel
The urgency of providing compr ...... for substance abusers with HIV
@ast
The urgency of providing compr ...... for substance abusers with HIV
@en
P2860
P1433
P1476
The urgency of providing compr ...... for substance abusers with HIV
@en
P2093
Julio Montaner
Nora D Volkow
P2860
P304
P356
10.1377/HLTHAFF.2011.0663
P407
P577
2011-08-01T00:00:00Z